Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

The FDA and Novartis have agreed to move forward with a Phase 3 clinical trial to evaluate the effectiveness of hydroxychloroquine in COVID-19...
A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy remdesivir in the fight...
Cases of coronavirus are set to be tracked by ethnicity in England following an announced government review.
The FDA has approved the United States’ first and only treatment for previously treated, unresectable locally advanced or metastatic...
The malaria treatment hydroxychloroquine is facing further scrutiny as a coronavirus treatment after failed trials in France.
Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the drug does...
The FDA has moved to authorise UroGen Pharma’s Jelmyto (mitomycin gel) in the US for the treatment of low-grade upper tract urothelial cancer (UTUC...
Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with the authorisation...
The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in development at British American...
Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 for the development...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches